Emcure’s Sanand Facility Clears US FDA Inspection with Zero Observations

Unknown Apr 02, 2026 950 Views

Emcure Pharmaceuticals Ltd has successfully concluded a PreApproval Inspection (PAI) by the US Food and Drug Administration (US FDA) at its oncology manufacturing facility in Sanand, Gujarat, with zero observations. Inspection Highlights: The inspection was conducted from J...